ART6043

· Artios Pharma Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ART6043, covering 2025-10-15 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of ART6043 in Advanced/Metastatic Solid Tumors Patients [Phase 1, Phase 2]